All aboard the public financing train! Zentalis, Editas, Verastem, Praxis and Clene, among others, raise funds

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.)  Health tech’s strug­gles to raise mon­ey bled

As­traZeneca’s rare dis­ease arm Alex­ion scored its fourth ap­proval for Ul­tomiris in a rare au­toim­mune dis­or­der af­ter Phase 3 da­ta showed there were ze­ro pa­tients with

Policy experts and former health officials cast their predictions on what health policy changes to expect from the next administration during an online panel discussion